Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Sep 30, 2025 | (FY)Jun 30, 2025 | (Q4)Jun 30, 2025 | (Q3)Mar 31, 2025 | (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -9.29%433.06M | -14.10%2.33B | -14.71%629.51M | -5.09%572.8M | 4.08%653.18M | -36.06%477.4M | 15.82%2.72B | 46.55%738.05M | 15.32%603.51M | -12.00%627.55M |
| Cost of revenue | -12.73%200.8M | -0.50%944.22M | -13.99%248.86M | 22.02%198.53M | 19.65%266.74M | -16.02%230.09M | 16.09%948.96M | 63.53%289.33M | 8.00%162.71M | -18.19%222.94M |
| Gross profit | -6.08%232.26M | -21.40%1.39B | -15.17%380.65M | -15.09%374.28M | -4.49%386.43M | -47.68%247.3M | 15.67%1.77B | 37.36%448.72M | 18.28%440.81M | -8.17%404.61M |
| Operating expense | -40.62%41.23M | -23.79%223.88M | -30.66%60.68M | -26.57%48.17M | -37.74%45.59M | 2.97%69.44M | -0.40%293.78M | 81.46%87.51M | 10.25%65.6M | -17.24%73.23M |
| Selling and administrative expenses | -40.62%41.23M | -23.79%223.88M | -30.66%60.68M | -26.57%48.17M | -37.74%45.59M | 2.97%69.44M | -0.40%293.78M | 81.46%87.51M | 10.25%65.6M | -17.24%73.23M |
| -General and administrative expense | -40.62%41.23M | -23.79%223.88M | -30.66%60.68M | -26.57%48.17M | -37.74%45.59M | 2.97%69.44M | -0.40%293.78M | 81.46%87.51M | 10.25%65.6M | -17.24%73.23M |
| Operating profit | 7.40%191.02M | -20.92%1.16B | -11.42%319.97M | -13.09%326.1M | 2.86%340.84M | -56.10%177.87M | 19.52%1.47B | 29.73%361.21M | 19.81%375.2M | -5.89%331.37M |
| Net non-operating interest income (expenses) | -132.26%-34.45M | -86.09%-108.49M | -169.58%-35.12M | -100.19%-28.24M | -97.26%-30.3M | 6.16%-14.83M | 6.26%-58.3M | 21.11%-13.03M | -19.88%-14.11M | 15.29%-15.36M |
| Non-operating interest income | -51.91%4.53M | -47.18%25.63M | -58.79%5.24M | -57.80%5.39M | -54.25%5.59M | -13.04%9.42M | 222.11%48.53M | 81.75%12.7M | 132.59%12.78M | 792.40%12.22M |
| Non-operating interest expense | 60.74%38.98M | 25.55%134.12M | 56.82%40.35M | 25.08%33.63M | 30.14%35.89M | -8.96%24.25M | 38.28%106.83M | 9.48%25.73M | 55.76%26.89M | 41.41%27.58M |
| Net investment income | 5.55M | 656.27%20.94M | -78.31%4.18M | 194.21%1.97M | -37.62%5.06M | -49.73%2.77M | ||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 41K | 0 | 41K | 0 | 0 | 0 | ||||
| Income from associates and other participating interests | 72.91%-81K | -15.49%-589K | 6.45%-116K | -8.16%-106K | 56.69%-68K | -128.24%-299K | -139.78%-510K | -107.41%-124K | 29.50%-98K | -25.60%-157K |
| Special income (charges) | 31.26%-98.73M | -25.30%-81.1M | 99.83%-132K | -17.5M | -143.62M | -64.72M | -78.9M | 0 | ||
| Less:Impairment of capital assets | ---- | -39.24%87.27M | -53.89%28.13M | ---- | ---- | ---- | --143.62M | --61.01M | --78.9M | ---- |
| Less:Write off | ---- | --11.46M | 1,326.23%52.97M | -99.83%132K | --17.5M | ---- | --0 | --3.71M | --78.9M | --0 |
| Other non-operating income (expenses) | -7.29%-134.91M | -12.51%-603.8M | -34.41%-167.38M | -18.69%-169.36M | -4.14%-150.96M | 3.35%-125.74M | -12.11%-536.66M | -32.93%-124.53M | 10.38%-142.69M | -10.91%-144.95M |
| Income before tax | -26.64%27.14M | -52.14%353.21M | -77.45%36.26M | -11.19%128.3M | -6.17%162.96M | -85.73%36.99M | 3.65%738.08M | -4.20%160.77M | -3.79%144.46M | -16.78%173.68M |
| Income tax | 118.23%7.04M | -13.00%235.72M | -173.63%-38.35M | 472.67%244.28M | 11.71%79.7M | -136.82%-38.61M | -13.04%270.95M | 16.92%52.09M | -45.76%42.66M | -48.39%71.34M |
| Net income | -73.42%20.1M | -74.85%117.5M | -31.36%74.61M | -213.91%-115.97M | -18.64%83.26M | -51.00%75.6M | 16.63%467.12M | -11.84%108.68M | 42.37%101.81M | 45.22%102.34M |
| Net income continuous operations | -73.42%20.1M | -74.85%117.5M | -31.36%74.61M | -213.91%-115.97M | -18.64%83.26M | -51.00%75.6M | 16.63%467.12M | -11.84%108.68M | 42.37%101.81M | 45.22%102.34M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -73.42%20.1M | -74.85%117.5M | -31.36%74.61M | -213.91%-115.97M | -18.64%83.26M | -51.00%75.6M | 16.63%467.12M | -11.84%108.68M | 42.37%101.81M | 45.22%102.34M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -73.42%20.1M | -74.85%117.5M | -31.36%74.61M | -213.91%-115.97M | -18.64%83.26M | -51.00%75.6M | 16.63%467.12M | -11.84%108.68M | 42.37%101.81M | 45.22%102.34M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -71.38%0.0273 | -73.57%0.1539 | -25.64%0.1012 | -221.16%-0.154 | -15.09%0.108 | -50.23%0.0954 | 17.00%0.5822 | -11.16%0.1361 | 43.13%0.1271 | 45.37%0.1272 |
| Diluted earnings per share | -71.38%0.0273 | -73.57%0.1539 | -25.64%0.1012 | -221.16%-0.154 | -15.09%0.108 | -50.23%0.0954 | 17.00%0.5822 | -11.16%0.1361 | 43.13%0.1271 | 45.37%0.1272 |
| Dividend per share | -66.67%0.005 | 23.53%0.105 | 50.00%0.03 | 50.00%0.03 | -7.69%0.03 | 20.00%0.015 | 36.00%0.085 | 6.67%0.02 | 6.67%0.02 | 30.00%0.0325 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.